Navigation Links
New developments in biomarkers for epithelial ovarian cancer
Date:11/29/2007

AMSTERDAM, November 29th 2007 With the genomic revolution radical improvement has been made in methods of detection of ovarian cancer. This is of the utmost importance, since the chances of successful treatment are strongly enhanced with early detection. In a special issue of Disease Markers, published by IOS Press, eleven articles explore new developments in the identification and understanding of biomarkers for epithelial ovarian cancer.

Many of these biomarkers may serve not only as markers of clinical and biology interest but also as potential therapeutic and imaging targets which could significantly improve the survival of patients with this disease, states Prof. Michael J. Birrer (National Cancer Institute, Center for Cancer Research, Cell and Cancer Biology Department, MD, USA).

Discussed in the issue are new hypotheses on the molecular development of ovarian cancer, SP markers of risk, biomarkers that are specific for the different histological subtypes, and new biomarkers and approaches for the early detection of ovarian cancer. Furthermore, new molecular technologies have allowed for the analysis and characterization of specific cellular components of ovarian tumors identifying biomarkers of tumor associated immune and endothelial cells.


'/>"/>

Contact: Wilbert van der Sluijs
w.van.der.sluijs@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Page: 1

Related medicine news :

1. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
2. PainCare Reports on Key Corporate Developments
3. New Report Provides Insight Into Developments in the Market for Anxiety and Depression Therapies
4. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
5. MGT Capital Investments Reports Third Quarter 2007 Financial Results and Provides Update on Recent Developments
6. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
7. Study makes progress in zoning in on biomarkers for better colon cancer treatment
8. Biomarkers predict risk for invasive breast cancer years before the tumor develops
9. JDRF and Lilly partner to fund research to identify beta cell biomarkers
10. Biomarkers for Alzheimers disease can be trusted in clinical trials
11. Cranberry Could Juice Up Ovarian Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern ... Epilepsy Foundation in a community wide charity event with the goal of bringing in ... young local woman who lives with epilepsy, recently launched a charity campaign of her ...
(Date:7/21/2017)... ... 2017 , ... The Karen Miller Agency, a central Alabama ... greater Birmingham area, is joining the Chris Hammond Youth Foundation in a charity ... , The Chris Hammond Youth Foundation maintains athletic facilities in rural areas that ...
(Date:7/21/2017)... Grove, Ill. (PRWEB) , ... July 21, 2017 , ... ... & Fabric Liquid eco-friendly odor-control solution for colleges and universities at the ... safely and effectively eliminate severe cannabis and tobacco smoke odors without the use of ...
(Date:7/21/2017)... ... ... Hospital M&A activity slowed in the second quarter of 2017, according to new ... in the second quarter, up 15% from the 20 publicly announced acquisitions in the ... year-ago second quarter. Only four of the transactions disclosed a purchase price in the ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand ... Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... PARK, N.C. , July 10, 2017 ... $5m Convertible Note to support the development of CRISPR-Cas3 ... Tencent Holdings Limited, a leading Chinese Internet services provider, ... funding will advance multiple infectious disease product programs targeting ... Founded by Dr. Rodolphe ...
(Date:7/5/2017)... July 5, 2017   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade cell and tissue ... media ("BioLife"), today announced that it has reached an ... and largest shareholder, to modify its existing credit facility ... the modification, WAVI agreed to exchange its existing $4.25 ...
Breaking Medicine Technology: